Seeing Is Believing
Currently out of the existing stock ratings of Roy Buchanan, 34 are a BUY (94.44%), 2 are a HOLD (5.56%).
Analyst Roy Buchanan works at JMP with a stock forecast success ratio of 28.21% fulfilled within 68.78 days on average.
Roy Buchanan’s has documented 72 price targets and ratings displayed on 9 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ABUS, Arbutus Biopharma Corp at 04-Apr-2024.
Analyst best performing recommendations are on ENTA (ENANTA PHARMACEUTICALS).
The best stock recommendation documented was for ENTA (ENANTA PHARMACEUTICALS) at 11/8/2021. The price target of $77 was fulfilled within 11 days with a profit of $17.24 (18.29%) receiving and performance score of 16.63.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Sell
8
$5.49 (218.73%)
20
8 months 4 days ago
4/4 (100%)
$-0.89 (-10.01%)
32
Buy
24
$21.49 (856.18%)
34
11 months 30 days ago
0/5 (0%)
$16.73 (230.12%)
Hold
21
$18.49 (736.65%)
58
1 years 3 months 19 days ago
1/2 (50%)
$12.74 (154.24%)
63
Sell
47
3 years ago
1/1 (100%)
$-81.95 (-63.55%)
295
Which stock is Roy Buchanan is most bullish on?
Which stock is Roy Buchanan is most reserved on?
What Year was the first public recommendation made by Roy Buchanan?